drugset / Trial / NCT00176046
Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study
Phase 4
Completed
114 enrolled
Heidelberg University
Verein für Krebsforschung, Arlesheim, Swizzerland · collabWeleda AG, D-73525 Schwäbisch Gmünd · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this feasibility study is to identify appropriate surrogate parameters for a randomized study to examine the efficacy of a complementary therapy with an extract of viscum album (Iscador P) in patients with breast cancer.
Timeline
- Start
- 1999-05
- Primary completion
- 2009-06
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | viscum album pini | Unknown | 0.001 mg | Subcutaneous |
| Comparator | viscum album pini | Unknown | 20 mg | Subcutaneous |